托拉塞米联合低浓度多巴胺治疗老年心力衰竭利尿剂抵抗的临床价值分析

Analysis of Clinical Value of Torasemide Combined with Low Concentration Dopamine in the Treatment of Elderly Heart Failure Diuretic Resistance

目的分析托拉塞米联合低浓度多巴胺治疗老年心力衰竭利尿剂抵抗的临床价值。方法选择老年心力衰竭利尿剂抵抗患者64例,依据治疗方法将这些患者分为托拉塞米联合低浓度多巴胺治疗组(观察组,n=32)和呋塞米联合低浓度多巴胺治疗组(对照组,n=32)两组,对两组患者的体质量、心率、LVEF、BNP水平进行统计分析。结果观察组患者的体质量、心率、BNP水平均显著低于对照组(P<0.05),LVEF显著高于对照组(P<0.05)。结论托拉塞米联合低浓度多巴胺治疗老年心力衰竭利尿剂抵抗的临床价值较呋塞米联合低浓度多巴胺高。

Objective To analyze the clinical value of torasemide combined with low concentration dopamine in the treatment of elderly heart failure diuretic resistance. Methods 64 cases of elderly patients with heart failure diuretic resistance were selected, these patients were divided into torasemide combined with low concentration dopamine treatment group （observation group, n=32） and furosemide combined with low concentration dopamine treatment group （control group, n=32） two groups according to the treatment methods, the body weights, heart rates, LVEF, BNP levels of the two groups were statistically analyzed. Results The body weight, heart rate, BNP level of the observation group were significantly lower （P〈0.05）, the LVEF was significantly higher than the control group （P〈0.05）. Conclusion The clinical value of torasemide combined with low concentration dopamine in the treatment of elderly heart failure diuretic resistance is higher than furosemide combined with low concentration of dopamine.